Most of the Following Articles Are Available Online Via the NHS Scotland Elibrary. Please

Most of the following articles are available online via the NHS Scotland eLibrary. Please use the links where provided and your ATHENS password. A complete list of available online journals and registration for ATHENS can be found at http://www.elib.scot.nhs.uk/

If you would like to request print copies of any of the articles please contact your nearest library or visit the library website for further details.

http://www.nhsggc.org.uk/libraryservices

Please note inter-library requests will only be done for South Glasgow NHS staff.

Please note, the articles you are accessing may be protected by copyright legislation, please contact your librarian for a copyright declaration form if you are in any doubt. Or, consult the Copyright Licensing Agency at http://www.cla.co.uk

If you have any questions regarding this or any other library services please contact your librarian.

Compiled by C. Boulnois

Library Services Manager (South)

NHS Greater Glasgow & Clyde Library Network

Central Library

Southern General Hospital

1345 Govan Rd

G51 4TF

0141 201 2163

1. Manage levodopa-induced motor complications in patients with Parkinson's disease with careful selection of other antiparkinsonian agents. Drugs and Therapy Perspectives 2008;24:17-21.

2. Abdo WF, Van Norden AGW, De Laat KF, et al. Diagnostic accuracy of the clapping test in Parkinsonian disorders. J Neurol 2007;254:1366-9.

3. Aleyasin H, Rousseaux MW, Phillips M, et al. The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage. Proc Natl Acad Sci U S A 2007;104:18748-53.

4. Alice N, Fabienne C, Anne-Marie W, Kaat D. Does freezing in Parkinson's disease change limb coordination? A kinematic analysis. J Neurol 2007;254:1268-77.

5. Alimonti A, Bocca B, Pino A, Ruggieri F, Forte G, Sancesario G. Elemental profile of cerebrospinal fluid in patients with Parkinson's disease. Journal of Trace Elements in Medicine & Biology 2007;21:234-41.

6. Allain H, Bentue-Ferrer D, Akwa Y. Disease-modifying drugs and Parkinson's disease. Prog Neurobiol 2008;84:25-39.

7. Alvarez MV, Evidente VG, Driver-Dunckley ED. Differentiating Parkinson's disease from other parkinsonian disorders. Semin Neurol 2007;27:356-62.

8. Amick MM, Grace J, Ott BR. Visual and cognitive predictors of driving safety in Parkinson's disease patients. Archives of Clinical Neuropsychology 2007;22:957-67.

9. Antonini A. Continuous dopaminergic stimulation--from theory to clinical practice. Parkinsonism Relat Disord 2007;13:S24-8.

10. Arabia G, Grossardt BR, Geda YE, et al. Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease. Arch Gen Psychiatry 2007;64:1385-92.

11. Arbouw ME, van Vugt JP, Egberts TC, Guchelaar HJ. Pharmacogenetics of antiparkinsonian drug treatment: a systematic review. Pharmacogenomics 2007;8:159-76.

12. Arias-Vasquez A, de Lau L, Pardo L, et al. Relationship of the Ubiquilin 1 gene with Alzheimer's and Parkinson's disease and cognitive function. Neurosci Lett 2007;424:1-5.

13. Balami J, Robertson D. Parkinson's disease and sexuality. Br J Hosp Med 2007;68:644-7.

14. Baldwin CM, Keating GM. Rotigotine transdermal patch: A review of its use in the management of Parkinson's disease. CNS Drugs 2007;21:1039-55.

15. Bandini F, Primavera A, Pizzorno M, Cocito L. Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease. Parkinsonism Relat Disord 2007;13:369-71.

16. Bares M, Kanovsky P, Rektor I. Disturbed intracortical excitability in early Parkinson's disease is l-DOPA dose related: A prospective 12-month paired TMS study. Parkinsonism and Related Disorders 2007;13:489-94.

17. Barichella M, Savardi C, Mauri A, et al. Diet with LPP for renal patients increases daily energy expenditure and improves motor function in Parkinsonian patients with motor fluctuations. Nutr Neurosci 2007;10:129-35.

18. Barnes J, Boubert L. Executive functions are impaired in patients with Parkinson's disease with visual hallucinations. Journal of Neurology Neurosurgery and Psychiatry 2008;79:190-2.

19. Baziyan BK, Chigaleichik LA, Teslenko EL, Lachinova DR. Analysis of trajectories of eye, head, and hand movements for early diagnosis of Parkinson's disease. Bull Exp Biol Med 2007;143:553-5.

20. Berg D. Disturbance of iron metabolism as a contributing factor to SN hyperechogenicity in Parkinson's disease: implications for idiopathic and monogenetic forms. Neurochem Res 2007;32:1646-54.

21. Bialecka M, Klodowska-Duda G, Kurzawski M, et al. Interleukin-10 gene polymorphism in Parkinson's disease patients. Arch Med Res 2007;38:858-63.

22. Birdno MJ, Grill WM. Mechanisms of Deep Brain Stimulation in Movement Disorders as Revealed by Changes in Stimulus Frequency. Neurotherapeutics 2008;5:14-25.

23. Biswas A, Maulik M, Das SK, Indian Genome Variation C, Ray K, Ray J. Parkin polymorphisms: risk for Parkinson's disease in Indian population. Clin Genet 2007;72:484-6.

24. Boddy F, Rowan EN, Lett D, O'Brien JT, McKeith IG, Burn DJ. Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's disease with and without dementia, dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry 2007;22:529-35.

25. Bohnen NI, Kuwabara H, Constantine GM, Mathis CA, Moore RY. Grooved pegboard test as a biomarker of nigrostriatal denervation in Parkinson's disease. Neurosci Lett 2007;424:185-9.

26. Bonuccelli U, Pavese N. Role of dopamine agonists in Parkinson's disease: an update. Expert Review of Neurotherapeutics 2007;7:1391-9.

27. Bornebroek M, de Lau LM, Haag MD, et al. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Neuroepidemiology 2007;28:193-6.

28. Bostantjopoulou S, Katsarou Z, Petridis A. Relapsing hemiparkinsonism due to recurrent meningioma. Parkinsonism Relat Disord 2007;13:372-4.

29. Braak H, Sastre M, Del Tredici K. Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease. Acta Neuropathol 2007;114:231-41.

30. Brandt-Christensen M, Garcia Lopez A, Morkeberg Nilsson F, Kragh Andersen P, Vedel Kessing L. Parkinson's disease and antidepressant drug treatment: a case-register study. Parkinsonism Relat Disord 2007;13:406-10.

31. Breit S, Spieker S, Schulz JB, Gasser T. Long-term EMG recordings differentiate between parkinsonian and essential tremor. J Neurol 2008;255:103-11.

32. Brunenberg EJ, Vilanova A, Visser-Vandewalle V, et al. Automatic trajectory planning for deep brain stimulation: a feasibility study. Medical Image Computing & Computer-Assisted Intervention: MICCAI 2007;10:584-92.

33. Caballol N, Marti MJ, Tolosa E. Cognitive dysfunction and dementia in Parkinson disease. Movement Disorders 2007;22:S358-66.

34. Caccamo D, Gorgone G, Curro M, et al. Effect of MTHFR polymorphisms on hyperhomocysteinemia in levodopa-treated Parkinsonian patients. NeuroMolecular Medicine 2007;9:249-54.

35. Camargos S, Scholz S, Simon-Sanchez J, et al. DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA. Lancet Neurology 2008;7:207-15.

36. Cantello R, Tarletti R, Varrasi C, Cecchin M, Monaco F. Cortical inhibition in Parkinson's disease: New insights from early, untreated patients. Neuroscience 2007;150:64-71.

37. Carne W, Cifu DX, Marcinko P, et al. Efficacy of multidisciplinary treatment program on long-term outcomes of individuals with Parkinson's disease. Journal of Rehabilitation Research & Development 2005;42:779-86.

38. Carpinella I, Crenna P, Calabrese E, et al. Locomotor function in the early stage of Parkinson's disease. IEEE Transactions on Neural Systems and Rehabilitation Engineering 2007;15:543-51.

39. Castelli L, Lanotte M, Zibetti M, et al. Apathy and verbal fluency in STN-stimulated PD patients. An observational follow-up study. J Neurol 2007;254:1238-43.

40. Caviness JN, Hentz JG, Evidente VG, et al. Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease. Parkinsonism Relat Disord 2007;13:348-54.

41. Cersosimo MG, Piedimonte F, Raina GB, Micheli FE. Bilateral STN-DBS fails to improve non-motor fluctuations in a PD patient. Parkinsonism and Related Disorders 2007;13:537-8.

42. Chang CC, Liu JS, Chang YY, Chang WN, Chen SS, Lee CH. (99m)Tc-ethyl cysteinate dimer brain SPECT findings in early stage of dementia with Lewy bodies and Parkinson's disease patients: a correlation with neuropsychological tests. European Journal of Neurology 2008;15:61-5.

43. Chang C-, Liu J-, Chang Y-, Chang W-, Chen S-, Lee C-. 99mTc-ethyl cysteinate dimer brain SPECT findings in early stage of dementia with Lewy bodies and Parkinson's disease patients: A correlation with neuropsychological tests. European Journal of Neurology 2008;15:57-61.

44. Chen H, O'Reilly EJ, Schwarzschild MA, Ascherio A. Peripheral inflammatory biomarkers and risk of Parkinson's disease. Am J Epidemiol 2008;167:90-5.

45. Chen JJ, Swope DM. Pharmacotherapy for Parkinson's disease. Pharmacotherapy 2007;27:161S-73S.

46. Chen JJ, Swope DM, Dashtipour K. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease. Clin Ther 2007;29:1825-49.

47. Chen P, Kales HC, Weintraub D, et al. Depression in veterans with Parkinson's disease: frequency, co-morbidity, and healthcare utilization. Int J Geriatr Psychiatry 2007;22:543-8.

48. Chen P, Kales HC, Weintraub D, Blow FC, Jiang L, Mellow AM. Antidepressant treatment of veterans with Parkinson's disease and depression: analysis of a national sample. Journal of Geriatric Psychiatry & Neurology 2007;20:161-5.

49. Cheng EM, Siderowf AD, Swarztrauber K, et al. Disparities of care in veterans with Parkinson's disease. Parkinsonism and Related Disorders 2008;14:8-14.

50. Ciccarelli O. Diffusion tensor MRI for the differentiation of Parkinson's disease and multiple system atrophy: Commentary. Nature Clinical Practice Neurology 2007;3:544-5.

51. Cilia R, Marotta G, Landi A, et al. Cerebral activity modulation by extradural motor cortex stimulation in Parkinson's disease: a perfusion SPECT study. European Journal of Neurology 2008;15:22-8.

52. Cilia R, Marotta G, Landi A, et al. Cerebral activity modulation by extradural motor cortex stimulation in Parkinson's disease: A perfusion SPECT study. European Journal of Neurology 2008;15:18-24.

53. Clarke CE, Deane KHO. Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease. Cochrane Database Syst Rev 2007;.

54. Clarke CE, Deane KHO. Cabergoline for levodopa-induced complications in Parkinson's disease. Cochrane Database Syst Rev 2007;.

55. Clarke CE, Deane KHO. Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease. Cochrane Database Syst Rev 2007;.

56. Clarke CE, Deane KHO. Ropinirole for levodopa-induced complications in Parkinson's disease. Cochrane Database Syst Rev 2007;.

57. Clarke CE, Speller JM. Lisuride for levodopa-induced complications in Parkinson's disease. Cochrane Database Syst Rev 2007;.

58. Clarke CE, Speller JM. Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease. Cochrane Database Syst Rev 2007;.

59. Clarke CE, Speller JM. Pergolide versus bromocriptine for levodopa-induced complications in Parkinson's disease. Cochrane Database Syst Rev 2007;.

60. Clarke CE, Speller JM. Pergolide for levodopa-induced complications in Parkinson's disease. Cochrane Database Syst Rev 2007;.

61. Clarke CE, Speller JM, Clarke JA. Pramipexole for levodopa-induced complications in Parkinson's disease. Cochrane Database Syst Rev 2007;.

62. Clarke CE, Speller JM, Clarke JA. Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease. Cochrane Database Syst Rev 2007;.

63. Cookson MR, Dauer W, Dawson T, Fon EA, Guo M, Shen J. The roles of kinases in familial Parkinson's disease. Journal of Neuroscience 2007;27:11865-8.

64. Cordato DJ, Chan DK. Genetics and Parkinson's disease. Journal of Clinical Neuroscience 2004;11:119-23.

65. Costa A, Peppe A, Carlesimo GA, Salamone G, Caltagirone C. Neuropsychological correlates of alexithymia in Parkinson's disease. Journal of the International Neuropsychological Society 2007;13:980-92.

66. Cress DE. The need for regulatable vectors for gene therapy for Parkinson's disease. Exp Neurol 2008;209:30-3.

67. Crosby N, Deane KHO, Clarke CE. Amantadine in Parkinson's disease. Cochrane Database Syst Rev 2007;.

68. Crosby NJ, Deane KHO, Clarke CE. Beta-blocker therapy for tremor in Parkinson's disease. Cochrane Database Syst Rev 2007;.

69. Crosby NJ, Deane KHO, Clarke CE. Amantadine for dyskinesia in Parkinson's disease. Cochrane Database Syst Rev 2007;.

70. Crucian GP, Heilman K, Junco E, et al. The crossed response inhibition task in Parkinson's disease: disinhibition hyperkinesia. Neurocase 2007;13:158-64.

71. Cummings J, Winblad B. A rivastigmine patch for the treatment of Alzheimer's disease and Parkinson's disease dementia. Expert Review of Neurotherapeutics 2007;7:1457-63.

72. Dahodwala N, Connolly J, Farmer J, Stern MB, Jennings D, Siderowf A. Interest in predictive testing for Parkinson's disease: Impact of neuroprotective therapy. Parkinsonism and Related Disorders 2007;13:495-9.

73. Dara C, Monetta L, Pell MD. Vocal emotion processing in Parkinson's disease: Reduced sensitivity to negative emotions. Brain Res 2008;1188:100-11.

74. Dauer W. Neurotrophic factors and Parkinson's disease: the emergence of a new player?. Science's Stke [Electronic Resource]: Signal Transduction Knowledge Environment 2007;2007:e60.

75. de Bie RM, Miyasaki J, Lang AE, Fox SH. Clinical practice regarding dopamine-agonist use and driving in Parkinson's disease. Canadian Journal of Neurological Sciences 2007;34:438-42.

76. De Letter M, Santens P, Estercam I, et al. Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners. Clinical Linguistics & Phonetics 2007;21:783-91.

77. De Nunzio AM, Nardone A, Schieppati M. The control of equilibrium in Parkinson's disease patients: delayed adaptation of balancing strategy to shifts in sensory set during a dynamic task. Brain Res Bull 2007;74:258-70.

78. De Oliveira MA, Rodrigues AM, Da Silva Caballero RM, De Souza Petersen RD, Shim JK. Strength and isometric torque control in individuals with Parkinson's disease. Experimental Brain Research 2008;184:445-50.

79. Deane KHO, Jones D, EllisHill C, Clarke CE, Playford ED, BenShlomo Y. Physiotherapy for Parkinson's disease: a comparison of techniques. Cochrane Database Syst Rev 2007;.

80. Deane KHO, Jones D, Playford ED, BenShlomo Y, Clarke CE. Physiotherapy versus placebo or no intervention in Parkinson's disease. Cochrane Database Syst Rev 2007;.

81. Deane KHO, Spieker S, Clarke CE. Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease. Cochrane Database Syst Rev 2007;.

82. Deane KHO, Spieker S, Clarke CE. Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease. Cochrane Database Syst Rev 2007;.

83. Deane KHO, Whurr R, Clarke CE, Playford ED, BenShlomo Y. Non-pharmacological therapies for dysphagia in Parkinson's disease. Cochrane Database Syst Rev 2007;.

84. Deane KHO, Whurr R, Playford ED, BenShlomo Y, Clarke CE. Speech and language therapy for dysarthria in Parkinson's disease: a comparison of techniques. Cochrane Database Syst Rev 2007;.

85. Deane KHO, Whurr R, Playford ED, BenShlomo Y, Clarke CE. Speech and language therapy versus placebo or no intervention for dysarthria in Parkinson's disease. Cochrane Database Syst Rev 2007;.

86. Dhawan V, Eidelberg D. PET imaging in Parkinson's disease. Current Medical Imaging Reviews 2007;3:233-41.

87. Di Napoli M, Shah IM, Stewart DA. Molecular pathways and genetic aspects of Parkinson's disease: from bench to bedside. Expert Review of Neurotherapeutics 2007;7:1693-729.

88. Diamond A, Shahed J, Jankovic J. The effects of subthalamic nucleus deep brain stimulation on parkinsonian tremor. J Neurol Sci 2007;260:199-203.